The luminal subtype, mainly dominated by hormone receptor positive (HR+) tumors, and generally ER+, PR+, HER2 negative (HER2-), is the most common BC profile, accounting for about 60% of all BC tumors [17]. This evidence concerns the gene NR4A1 and breast cancer.